Contact
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
Key regions: Netherlands, Japan, France, Italy, China
The Diabetes Care Devices Market in Israel is experiencing considerable growth, fueled by advancements in technology, increasing prevalence of diabetes, and heightened awareness of disease management among patients, enhancing accessibility and treatment options.
Customer preferences: Consumers in Israel are increasingly prioritizing personalized diabetes management solutions, reflecting a growing preference for tailored health care experiences. This trend is driven by a tech-savvy population that values user-friendly diabetes care devices, such as smart glucose monitors and insulin pumps with connectivity features. Additionally, the rising awareness of preventive health measures and lifestyle modifications has led to a demand for integrated apps that provide real-time data and support, promoting proactive disease management and enhancing patient engagement.
Trends in the market: In Israel, the Diabetes Care Devices Market is experiencing a surge in demand for advanced glucose monitoring systems, including continuous glucose monitors (CGMs) and smart insulin delivery systems. This trend reflects a shift towards more integrated diabetes management solutions that enhance patient autonomy and enable real-time data sharing with healthcare providers. The increasing prevalence of diabetes, coupled with a rising emphasis on preventive care, is driving the development of apps that support lifestyle adjustments and medication adherence. For industry stakeholders, these trends signify a need for investment in innovative technologies and partnerships that enhance user experience and engagement, ultimately improving patient outcomes.
Local special circumstances: In Israel, the Diabetes Care Devices Market is uniquely influenced by a strong technological ecosystem and a high level of health awareness among the population. The country's advanced research and development capabilities foster innovation in diabetes management technologies, particularly in smart devices and apps designed for real-time monitoring. Additionally, cultural attitudes towards preventive health and lifestyle management encourage widespread adoption of these devices. Regulatory support for digital health solutions further accelerates market growth, positioning Israel as a leader in diabetes care innovation.
Underlying macroeconomic factors: The Diabetes Care Devices Market in Israel is significantly shaped by macroeconomic factors such as national economic stability, healthcare investment, and global market trends. Israel’s robust economy, characterized by high GDP per capita and strong tech sector growth, fosters innovation in medical technology. Government fiscal policies that prioritize healthcare funding and support for research and development further enhance the environment for diabetes care solutions. Additionally, global trends towards preventive healthcare and personalized medicine are driving local demand for advanced diabetes management devices, ensuring continuous market expansion and adoption of innovative technologies.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)